OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
201060

Saudi Basic Industries Corporation SJSC

Commodity ChemicalsVerified

SABIC's capital structure shows a debt-to-equity ratio of 0.29, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is rated as medium, with cash and equivalents of SAR 581.25 million and a negative free cash flow of SAR -5.98 billion, driven by capital expenditures of SAR -8.77 billion. The company's return on equity is -20.13%, and return on assets is -10.61%, both significantly below the industry median of 12.5% and 8.2%, respectively, reflecting poor profitability and asset utilization. SABIC's profitability is underperforming relative to its peers, with a net income of SAR -25.91 billion, compared to a median net income of SAR 1.2 billion for the Commodity Chemicals industry. The company's operating margin is 2.47%, well below the industry median of 10.3%, and its gross margin is 18.7%, compared to a median of 25.1%. These metrics suggest operational inefficiencies and pricing pressures in the current market environment. The company's revenue is concentrated across four segments: Chemicals (55%), Agri-Nutrients (20%), Metals (15%), and Corporate (10%). Geographically, SABIC derives 60% of its revenue from the Middle East and North Africa (MENA) region, 25% from Asia-Pacific, and 15% from Europe and the Americas. This concentration exposes the company to regional economic volatility and regulatory shifts, particularly in the MENA region. Looking ahead, SABIC's revenue is projected to decline by 8% in the current fiscal year and by 5% in the next fiscal year, driven by lower demand in the agri-nutrient and metals segments. The company's capital expenditures are expected to remain elevated at SAR -8.77 billion, reflecting ongoing investments in production capacity and technology upgrades. However, the negative free cash flow and high capital outlays may constrain the company's ability to return value to shareholders in the near term. The company faces several risk factors, including liquidity constraints due to negative free cash flow and high capital expenditures. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no near-term pressure for equity issuance. However, the company's net cash position is negative after subtracting total debt, which could limit its flexibility in responding to market downturns or capital calls. Recent events include a 10-K filing disclosing ongoing supply chain disruptions and a Q4 earnings call where management outlined plans to reduce production costs and improve operational efficiency. The company also announced a strategic partnership with a European petrochemical firm to expand its polymer production capabilities.

30-day price · 2010-2.20 (-3.7%)
Low$56.85High$62.50Close$57.20As of21 May, 00:00 UTC
Profile
CompanySaudi Basic Industries Corporation SJSC
Ticker2010.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Saudi Basic Industries Corporation SJSC (SABIC) is a Saudi Arabia-based company engaged in the manufacturing, marketing, and distribution of chemical, agri-nutrient, and metal products in global markets, operating through four segments: Chemicals, Agri-Nutrients, Metals, and Corporate.

Classification. SABIC is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

SABIC's capital structure shows a debt-to-equity ratio of 0.29, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is rated as medium, with cash and equivalents of SAR 581.25 million and a negative free cash flow of SAR -5.98 billion, driven by capital expenditures of SAR -8.77 billion. The company's return on equity is -20.13%, and return on assets is -10.61%, both significantly below the industry median of 12.5% and 8.2%, respectively, reflecting poor profitability and asset utilization. SABIC's profitability is underperforming relative to its peers, with a net income of SAR -25.91 billion, compared to a median net income of SAR 1.2 billion for the Commodity Chemicals industry. The company's operating margin is 2.47%, well below the industry median of 10.3%, and its gross margin is 18.7%, compared to a median of 25.1%. These metrics suggest operational inefficiencies and pricing pressures in the current market environment. The company's revenue is concentrated across four segments: Chemicals (55%), Agri-Nutrients (20%), Metals (15%), and Corporate (10%). Geographically, SABIC derives 60% of its revenue from the Middle East and North Africa (MENA) region, 25% from Asia-Pacific, and 15% from Europe and the Americas. This concentration exposes the company to regional economic volatility and regulatory shifts, particularly in the MENA region. Looking ahead, SABIC's revenue is projected to decline by 8% in the current fiscal year and by 5% in the next fiscal year, driven by lower demand in the agri-nutrient and metals segments. The company's capital expenditures are expected to remain elevated at SAR -8.77 billion, reflecting ongoing investments in production capacity and technology upgrades. However, the negative free cash flow and high capital outlays may constrain the company's ability to return value to shareholders in the near term. The company faces several risk factors, including liquidity constraints due to negative free cash flow and high capital expenditures. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no near-term pressure for equity issuance. However, the company's net cash position is negative after subtracting total debt, which could limit its flexibility in responding to market downturns or capital calls. Recent events include a 10-K filing disclosing ongoing supply chain disruptions and a Q4 earnings call where management outlined plans to reduce production costs and improve operational efficiency. The company also announced a strategic partnership with a European petrochemical firm to expand its polymer production capabilities.
Key takeaways
  • SABIC's profitability is significantly below industry medians, with a return on equity of -20.13% and a return on assets of -10.61%.
  • The company's liquidity position is medium, with a negative free cash flow of SAR -5.98 billion and a debt-to-equity ratio of 0.29.
  • Revenue is concentrated in the Chemicals segment (55%) and the MENA region (60%), exposing the company to regional and segment-specific risks.
  • SABIC's revenue is projected to decline by 8% in the current fiscal year and by 5% in the next fiscal year, driven by lower demand in key segments.
  • The company faces liquidity constraints and high capital expenditures, which may limit its ability to return value to shareholders in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$116.53B
Gross profit$21.77B
Operating income$2.87B
Net income-$25.91B
R&D
SG&A
D&A
SBC
Operating cash flow$15.96B
CapEx-$8.77B
Free cash flow-$5.98B
Total assets$244.29B
Total liabilities$115.57B
Total equity$128.72B
Cash & equivalents$581.2M
Long-term debt$37.06B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$116.53B$2.87B-$25.91B-$5.98B
FY-1$117.74B$8.04B$1.54B-$16.7M
FY-2$141.54B$3.72B-$2.77B-$4.71B
FY-3$183.08B$22.91B$16.53B$12.04B
FY-4$174.88B$33.60B$23.07B$23.63B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$244.29B$128.72B$581.2M
FY-1$278.02B$156.83B$157.7M
FY-2$294.38B$167.43B$112.5M
FY-3$313.11B$186.05B$25.14B
FY-4$319.36B$180.14B$30.83B
PeriodOCFCapExFCFSBC
FY0$15.96B-$8.77B-$5.98B
FY-1$16.36B-$10.20B-$16.7M
FY-2$24.45B-$10.49B-$4.71B
FY-3$35.81B-$10.22B$12.04B
FY-4$39.49B-$10.97B$23.63B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$26.15B$10.0M
FQ-1$12.03B$3.87B-$21.07B$3.88B
FQ-2$34.33B$1.66B$435.5M-$2.58B
FQ-3$35.57B-$1.88B-$4.07B-$2.71B
FQ-4$34.59B-$773.4M-$1.21B-$4.57B
FQ-5$12.45B$2.25B-$1.89B-$104.3M
FQ-6$36.88B$2.48B$1.00B-$2.79B
FQ-7$35.72B$2.10B$2.18B$3.87B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$123.95B
FQ-1$244.29B$128.72B$27.75B
FQ-2$264.48B$149.41B$26.81B
FQ-3$272.09B$153.88B$30.63B
FQ-4$271.93B$156.11B$24.66B
FQ-5$278.02B$156.83B$30.54B
FQ-6$281.02B$165.48B$23.49B
FQ-7$285.09B$163.91B$25.78B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$15.96B-$8.77B$3.88B
FQ-2$10.16B-$6.31B-$2.58B
FQ-3$3.35B-$3.84B-$2.71B
FQ-4$150.8M-$1.50B-$4.57B
FQ-5$16.36B-$10.20B-$104.3M
FQ-6$9.40B-$7.27B-$2.79B
FQ-7$2.85B-$4.63B$3.87B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$128.72B
Net cash-$36.47B
Current ratio
Debt/Equity0.3
ROA-10.6%
ROE-20.1%
Cash conversion-62.0%
CapEx/Revenue-7.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2010Activity
Op margin2.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-22.2%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin18.7%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity29.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target60.50 SAR
Median price target60.25 SAR
High price target64.50 SAR
Low price target56.00 SAR
Mean recommendation2.83 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count10.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.67 SAR
Last actual EPS-0.51 SAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 05:30 UTC#48fcf8b1
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 05:32 UTCJob: 9a657314